Description of Medical ServiceTisagenlecleucel is an autologous, murine anti-CD19 chimeric antigen receptor T cell (CAR-T) therapeutic process, involving harvesting, modifying, expanding and re-infusing a patient's own immune T-cells, to target and destroy certain cancerous cells.
Description of Medical ConditionAcute lymphoblastic leukaemia (ALL) is the malignant proliferation of lymphoid progenitor cells in the bone marrow.
Diffuse large B-cell lymphoma (DLBCL) is an aggressive and common subtype of Non-Hodgkin lymphoma (NHL).
Reason for ApplicationNew non-MBS item
Medical Service TypeHybrid health technology
Previous Application NumberNot Applicable
Application FormApplication Form (PDF 842 KB)
Application Form (Word 498 KB)
Consultation SurveyConsultation Survey (PDF 113 KB)
Consultation Survey (Word 508 KB)